Health Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV. Nirsevimab, also known by its brand name Beyfortus, was authorized on April 19. It was developed by AstraZeneca and Sanofi.  #cbc | top stories news #ifttt

Drug to help prevent serious RSV illness in babies approved by Health Canada Health Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV. Nirsevimab, also known by its brand name Beyfortus, was authorized on April 19. It was developed by AstraZeneca and Sanofi.  Tags: cbc | top stories news, ifttt via Pocket https://ift.tt/c5PvOsp April 24, 2023 at 06:53PM

Drug to help prevent serious RSV illness in babies approved by Health Canada Health Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV. Nirsevimab, also known by its brand name Beyfortus, was authorized on April 19. It was developed by AstraZeneca and Sanofi.  Tags: drug to help prevent seri via Pocket https://ift.tt/c5PvOsp April 24, 2023 at 07:14PM